Lincoln Pharmaceuticals Limited

Equities

LINCOLN

INE405C01035

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:48 2024-05-17 am EDT 5-day change 1st Jan Change
576.9 INR +0.46% Intraday chart for Lincoln Pharmaceuticals Limited +1.35% -5.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2024 CI
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director CI
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23 CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023 CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22 CI
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022 CI
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022 CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2022 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Chart Lincoln Pharmaceuticals Limited
More charts
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceuticals products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
More about the company
  1. Stock Market
  2. Equities
  3. LINCOLN Stock
  4. News Lincoln Pharmaceuticals Limited
  5. Lincoln Pharmaceuticals : Buys Facility for Antimicrobial Drug Production
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW